Utilization review of concomitant use of potentially interacting drugs in Thai patients using warfarin therapy

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 2, 2007, Pages 216-222

  Kotirum, Surachai ^a   Chaiyakunapruk, Nathorn ^a   Jampachaisri, Katechan ^a   Wattanasombat, Supharat ^b   Rojnuckarin, Ponlapat ^c  

^a NARESUAN UNIVERSITY   (Thailand)

^b Chiang Rai Prachanukhro Hospital   (Thailand)

^c CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Drug interactions; INR (International Normalise Ratio); Thailand; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; CARBAMAZEPINE; CIMETIDINE; CIPROFLOXACIN; COTRIMOXAZOLE; DEXAMETHASONE; DICLOFENAC; ERYTHROMYCIN; FLUCONAZOLE; GEMFIBROZIL; GRISEOFULVIN; IBUPROFEN; INDOMETACIN; LEVOTHYROXINE; MEFENAMIC ACID; METRONIDAZOLE; NAPROXEN; NORFLOXACIN; OFLOXACIN; OMEPRAZOLE; PARACETAMOL; PHENOBARBITAL; PHENYTOIN; PROPYLTHIOURACIL; RIFAMPICIN; SIMVASTATIN; THIAMAZOLE; UNINDEXED DRUG; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; DRUG ANTAGONISM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT COUNSELING; PATIENT MONITORING; PRIORITY JOURNAL; THAILAND; UTILIZATION REVIEW;

ACETAMINOPHEN; ADULT; AMBULATORY CARE; ANALGESICS, NON-NARCOTIC; ANTICOAGULANTS; ANTITHYROID AGENTS; ASPIRIN; DICLOFENAC; DRUG INTERACTIONS; DRUG MONITORING; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; POLYPHARMACY; PROPYLTHIOURACIL; RETROSPECTIVE STUDIES; THAILAND; WARFARIN;

EID: 33847166101     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1300     Document Type: Article

References (16)

1. Ginsberg JS. Drug therapy: management of venous thromboembolism. N Engl J Med 1996; 335: 1816-1829.
2. Welty TE. Cerebrovascular disorders. In Applied therapeutics the clinical use of drugs (8th edn). Koda-Kimble MA, Young LY, Kradjan WA, Guglielmo BJ (eds). Lippincott Williams & Wilkins: Maryland, 2005. 55.10-55.11.
3. Weitz JI, Hirsh J, Samama MM. New anticoagulant drugs: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126: 2655-2865.
4. Ansell J, Hirsh J, Dalen J, et al. Managing oral anticoagulant therapy. CHEST 2001; 119: 22S-38S.
5. Sanoski CA, Bauman JL. Clinical observations with the amiodarone/ warfarin interaction: dosing relationships with long-term therapy. Chest 2002; 121(1): 19-23.
6. Knijff-Dutmer EAJ, Van der Palen J, Schut G, Van de Laar MAFJ. The influence of cyclo-oxygenase specificity of non-steroidal anti-inflammatory drugs on bleeding complications in concomitant coumarine users. Q J Med 2003; 96: 513-520.
7. Bak S, Andersen M, Tsiropoulos I, et al. Risk of stroke associated with nonsteroidal anti-inflammatory drugs a nested case-control study. Stroke 2003; 34: 379-386.
8. Wells PS, Holbrook AM, Crowther NR, et al. The interaction of warfarin with drugs and food: a critical review of the literature. Ann Intern Med 1994; 121: 676-683.
9. Tatro DS (ed). Drug interaction facts. Wolters Kluwer. St. Louis, MO, 2005. xi-xvi, 1697-1698.
10. Hansten PD, Horn JR. Managing clinically important drug interactions. Wolters Kluwer Health: Missouri, 2004: 11.
11. Wittkowsky AK, Boccuzzi SJ, Wogen J, et al. Frequency of concomitant use of warfarin with potentially interacting drugs. Pharmacotherapy 2004; 24(12): 1668-1674.
12. Howard PA, Ellerbeck EF, Engelman KK, et al. The nature and frequency of potential warfarin drug interactions that increase the risk of bleeding in patients with atrial fibrillation. Pharmacoepidemiol Drug Saf 2002 October-November; 11(7): 569-576.
13. Hylek EM, Heiman H, Skates SJ, et al. Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA 1998 Mar 4; 279(9): 657-662.
14. Siguret V, Esquirol C, Debray M, et al. Excess antivitamin K in elderly hospitalised patients aged over 70. A one-year prospective survey [abstact]. Presse Med 2003; 32: 972-977.
15. Ebbesen J, Buajordel I, Erikssen J, et al. Drug-related deaths in a department of internal medicine. Arch Intern Med 2001; 161: 2317-2323.
16. Schulman S. Care of patients receiving long-term anticoagulant therapy. N Engl J Med 2003; 349: 675-683.